These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 12610556

  • 1. Japan launches new life-science initiatives.
    Triendl R.
    Nat Biotechnol; 2003 Mar; 21(3):218. PubMed ID: 12610556
    [No Abstract] [Full Text] [Related]

  • 2. Little science, big bucks.
    DeFrancesco L.
    Nat Biotechnol; 2003 Oct; 21(10):1127-9. PubMed ID: 14520387
    [No Abstract] [Full Text] [Related]

  • 3. Japanese council urges reform of funding system.
    Triendl R.
    Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656
    [No Abstract] [Full Text] [Related]

  • 4. Health-funding boost not enough for Canada.
    McElhaney RN.
    Nature; 2001 May 17; 411(6835):237. PubMed ID: 11357101
    [No Abstract] [Full Text] [Related]

  • 5. The changing norms of the life sciences.
    Shorett P, Rabinow P, Billings PR.
    Nat Biotechnol; 2003 Feb 17; 21(2):123-5. PubMed ID: 12560827
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rainbow biotech--South Africa's emerging sector.
    Louët S.
    Nat Biotechnol; 2006 Nov 17; 24(11):1313-6. PubMed ID: 17093464
    [No Abstract] [Full Text] [Related]

  • 8. India aims to become the main bioinformatics hub.
    Jayaraman KS, Louët S.
    Nat Biotechnol; 2004 Aug 17; 22(8):933. PubMed ID: 15286632
    [No Abstract] [Full Text] [Related]

  • 9. Italy: a performance review.
    Galavotti P.
    Med Device Technol; 2003 Jun 17; 14(5):32-3. PubMed ID: 12852121
    [No Abstract] [Full Text] [Related]

  • 10. Increasing number of companies found ineligible for SBIR funding.
    Bouchie A.
    Nat Biotechnol; 2003 Oct 17; 21(10):1121-2. PubMed ID: 14520384
    [No Abstract] [Full Text] [Related]

  • 11. US budget/Bioshield initiative emphasizes bioterrorism countermeasures.
    Fox JL.
    Nat Biotechnol; 2003 Mar 17; 21(3):216. PubMed ID: 12610554
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Report: EuroBioFund first annual forum in Helsinki.
    Biotechnol J; 2007 Apr 17; 2(4):406-7. PubMed ID: 17407205
    [No Abstract] [Full Text] [Related]

  • 15. Scientific workforce. Poor job market blunts impact of new master's programs.
    Bhattacharjee Y.
    Science; 2003 Aug 08; 301(5634):752-3. PubMed ID: 12907772
    [No Abstract] [Full Text] [Related]

  • 16. Switzerland's medical technology potential.
    Med Device Technol; 2004 Mar 08; 15(2):41-2. PubMed ID: 15154339
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Germany biotech gets second chance.
    Sheridan C.
    Nat Biotechnol; 2003 Dec 08; 21(12):1414-5. PubMed ID: 14647310
    [No Abstract] [Full Text] [Related]

  • 20. Marketing biotechnology with a Gallic flair.
    Jouanneau AC.
    Nat Biotechnol; 2003 Jul 08; 21 Suppl():BE36-7. PubMed ID: 12874977
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.